Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 457-690-5 | CAS number: 23432-65-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
In vitro gene mutation:
Bacterial reverse mutation assay (Ames test / OECD 471): negative
In vitro mammalian chromosome aberration test (CA / OECD 473): ambiguous
In vitro mammalian cell micronucleus test (MNT / OECD 487): negative
In vitro mammalian cell gene mutation assay (MLA / OECD 490): negative
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 20 Nov 2003 - 07 Jan 2004
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- adopted 1997
- Deviations:
- yes
- Remarks:
- 2-aminoanthracene was used as the sole indicator of the efficacy of the S9-mix
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Bayerisches Landesamt für Arbeitsschutz, Arbeitsmedizin und Sicherheitstechnik, München, Germany
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- His operon
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- S. typhimurium TA 102
- Metabolic activation:
- with and without
- Metabolic activation system:
- cofactor supplemented post-mitochondrial fraction (S9 mix), prepared from the livers of rats treated with Phenobarbital/beta-Naphtoflavone.
- Test concentrations with justification for top dose:
- 31.6, 100, 316, 1000, 2500, 5000 µg/plate
- Vehicle / solvent:
- - Vehicle/solvent used: DMSO
- Justification for choice of solvent/vehicle: The solvent was compatible with the survival of the bacteria and the S9 activity. - Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- methylmethanesulfonate
- other: 4-nitro-o-phenylene-diamine (4-NOPD), 2-aminoanthracene (2-AA)
- Remarks:
- Without S9: sodium azide (10 µg/plate for TA 100 and TA 1535); 4-NOPD (10 and 40 µg/plate for TA 98 and TA 1537); MMS (1 µL/plate for TA 102); With S9: 2-AA (2.5 µg/plate for TA 98, TA 100, TA 1535, TA 1537; 10 µg/plate for TA 102)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation); preincubation
DURATION
- Preincubation period: 60 minutes
- Exposure duration: 48 h
NUMBER OF REPLICATIONS: 3 plates per concentration in two independent experiments (plate incorporation and preincubation)
DETERMINATION OF CYTOTOXICITY
- Method: reduced background lawn, reduction in the number of revertants, degree of survival of treated cultures
METABOLIC ACTIVATION
The S9 fraction was stored in liquid nitrogen. The S9 mix was freshly prepared on the day of the test according to AMES (1933): containing 15% S9 and the following components (final concentrations):
- 8 mM MgCl2
- 33 mM KCI-salt solution
- 5 mM glucose-6-phosphate
- 5 mM NADP
in 100 mM phosphate buffer, pH 7.4 - Evaluation criteria:
- A test item is considered as mutagenic if:
- a dose-related increase in the number of revertants occurs and/or
- a reproducible biologically relevant positive response for at least one of the dose groups occurs in at least one strain with or without metabolic activation
A biologically relevant increase is described as follows:
- if in strains TA 100 and TA 102 the number of reversions is at least twice as high
- if in strains TA 1535, TA 1537 and TA 98 the number of reversions is at least three times higher
as compared to the spontaneous reversion rate. - Statistics:
- Mean values and standard deviation were calculated
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: no precipitation was reported
RANGE-FINDING/SCREENING STUDIES:
In a preliminary toxicity test TA 98 and TA 100 were treated with the test item up to 5000 µg/plate. No toxicity was observed up to 5000 µg/plate.
COMPARISON WITH HISTORICAL CONTROL DATA: no data given - Conclusions:
- Interpretation of results::
negative - Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 23 Sep 2003 - 05 Jan 2004
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Version / remarks:
- (1997)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Bayerisches Landesamt für Arbeitsschutz, Arbeitsmedizin und Sicherheitstechnik, München, Germany
- Type of assay:
- other: in vitro mammalian chromosome aberration test
- Target gene:
- Not applicable
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- Complete culture medium: MEM medium supplemented with 10% (v/v) fetal calf serum (FCS)
Treatment medium: MEM medium supplemented with 10% (v/v) fetal calf serum (FCS) - Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 liver microsomal fraction of phenobarbital and β-naphtoflavone induced rats
- Test concentrations with justification for top dose:
- - Pre-experiment:
- 15.6, 31.3, 62.5, 125, 250, 500, 1000, 2500, 5000 μg/mL (with and without metabolic activation)
Experiment I:
- 125, 250, 500, 1000, 2500, 5000 μg/mL (with and without metabolic activation)
Experiment II:
- 125, 250, 500, 1000, 2500, 5000 μg/mL (without metabolic activation)
- 500, 1000, 2000, 3000, 4000, 5000 μg/mL (with metabolic activation) - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: The solvent was compatible with the survival of the cells and the S9 activity. - Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- ethylmethanesulphonate
- Remarks:
- Ethylmethanesulfonate: 600 μg/mL in nutrient medium, -S9; Cyclophosphamide: 0.83 μg/mL in nutrient medium, +S9
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION:
- Exposure duration: 4 and 20 h
- Fixation time (start of exposure up to fixation or harvest of cells): 4 h treatment: 24 h; 20 h treatment: 20 h
SPINDLE INHIBITOR:
- colcemide 0.2 μg/mL medium
STAIN: Giemsa
NUMBER OF REPLICATIONS: 2
NUMBER OF CELLS EVALUATED: 200 per culture
DETERMINATION OF CYTOTOXICITY
- Method: mitotic index of 1000 cells
OTHER EXAMINATIONS:
Determination of polyploidy: yes - Evaluation criteria:
- There are several criteria for determining a positive result:
- a clear and dose-related increase in the number of cells with aberrations,
- a biologically relevant response for at least one of the dose groups, which is higher than the laboratory negative control range (up to 4.5% aberrant cells).
According to the OECD guidelines, the biological relevance of the results will be the criterion for the interpretation of the results, a statistical evaluation of the results is not regarded as necessary. However, for the interpretation of the data both, biological and if evaluated, statistical significance should be considered together. A test item is considered to be negative if there is no biologically relevant increase in the percentage of aberrant cells above concurrent control levels, at any dose group. - Statistics:
- Mean values and standard deviation have been calculated.
- Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with
- Genotoxicity:
- ambiguous
- Remarks:
- positiv at 2500 and 5000 µg/mL in experiment I, negativ in experiment II
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- ≥4000 µg/mL (experiment II)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- without
- Genotoxicity:
- ambiguous
- Remarks:
- negative in experiment I and positive at 2500 µg/mL in experiment II
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- ≥250 µg/mL (experiment I) and ≥500 µg/mL (experiment II)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TESTSPECIFIC CONFOUNDING FACTORS
Precipitation: No precipitation of the test item was noted in all dose groups evaluated and no influence on the pH values for the cell culture medium was detected.
COMPARISON WITH HISTORICAL CONTROL DATA:
In experiment I without metabolic activation the test item did not increase the frequency of the cells with aberrations as compared to the concurrent solvent control. In the cultures treated 1.5 – 5.0% aberrant cells were found which was slightly above the range of the historical negative control values. The results with metabolic activation showed a distinct increase in the aberrant cells at the highest dose groups evaluated. In the cultures treated 5.0 – 8.5% aberrant cells were found. Compared to the solvent controls the test item increased the frequency of aberrant cells at doses of 2500 µg/mL and 5000 µg/mL. The solvent controls showed values of 3.0% aberrant cells with and 2.0% aberrant cells without metabolic activation.
In experiment II without metabolic activation the number of aberrant cells observed at a dose of 2500 µg/mL were above the range of the concurrent solvent control value (4.0%) and even the historical negative control data. In the treated cultures 3.0 – 7.0% aberrant cells were found. The highest evaluable concentration (2500 µg/mL) showed a distinct but not statistically significant increase of aberrant cells. In experiment II with metabolic activation closer concentration steps were chosen to verify the results of experiment I. The increase in aberrant cells in experiment I could not be verified. The number of aberrant cells was 4.5 – 5.5%. The values were slight above the concurrent solvent control but not statistically different from the solvent control. The concurrent negative controls showed values of 1.0 and 3.0% aberrant cells (experiment I) and 2.0 and 1.8% aberrant cells (experiment II) without and with metabolic activation, respectively.
The positive controls EMS and CPA showed a distinct and biologically relevant increase of cells with structural chromosome aberrations above the historical positive control level (experiment II without metabolic activation). As experiment I (positive with metabolic activation) and experiment II (positive without metabolic activation) gave contradictory results there is no conclusive evidence as to whether the test substance is clastogenic or not under the applied test conditions. Therefore the results are considered ambiguous.
RANGEFINDING/SCREENING STUDIES:
According to the used OECD guideline the highest recommended concentration tested was 5000 μg/mL. Cytotoxicity was observed at concentrations ≥500 µg/mL (without metabolic activation) and 5000 µg/mL (with metabolic activation), respectively.
POLYPLOIDY:
No increase in the frequencies of polyploidy cells was found after treatment with the test item as compared to the controls in both experiments. - Conclusions:
- Interpretation of results: ambiguous
In conclusion, it can be stated that during the described in vitro chromosomal aberration test and under the experimental conditions reported, the test item SLM 449008 led to inconclusive results in the V79 chinese hamster cell line. Therefore, it was not possible to classify the test item as clastogenic or non-clastogenic. - Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2015-11-09 to 2016-03-22
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 490 (In Vitro Mammalian Cell Gene Mutation Tests Using the Thymidine Kinase Gene)
- Version / remarks:
- 29 July 2016
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit
- Type of assay:
- other: gene mutation assay in mammalian cells
- Target gene:
- Thymidine kinase locus
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Details on mammalian cell type (if applicable):
- CELLS USED
- Cell cycle length, doubling time or proliferation index: 10-12 h
- Modal number of chromosomes: 40 ± 2
MEDIA USED
- Type and identity of media including CO2 concentration if applicable: RPMI 1640 complete
medium
- Properly maintained: yes
- Periodically checked for Mycoplasma contamination: yes
- Periodically checked for karyotype stability: yes
- Periodically 'cleansed' against high spontaneous background: yes - Metabolic activation:
- with and without
- Metabolic activation system:
- phenobarbital/β-naphtholflavone induced rat liver S9-mix
- Test concentrations with justification for top dose:
- Preliminary experiment:
Without S9 mix: 0.10, 0.25, 0.5, 1.0, 2.5, 5.0, 7.5, or 10 mM (4 h)
With S9 mix: 0.10, 0.25, 0.5, 1.0, 2.5, 5.0, 7.5, or 10 mM (4 h)
Experiment:
Without S9 mix: 0.10, 0.25, 0.5, 1.0, 2.5, 5.0, 7.5, or 10 mM (4 h)
With S9 mix: 0.10, 0.25, 0.5, 1.0, 2.5, 5.0, 7.5, or 10 mM (4 h) - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: tetrahydrofuran (THF)
- Justification for choice of solvent/vehicle: THF was selected based on the solubility test of the test item; the solvent was compatible with the survival of the cells and S9 activity. - Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Remarks:
- THF
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- benzo(a)pyrene
- ethylmethanesulphonate
- methylmethanesulfonate
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in RPMI medium with 5% horse serum
- Cell density at seeding: adjusted daily to 3 x 10E5
DURATION
- Exposure duration: 4 h
- Expression time (cells in growth medium): 2 days
- Selection time (if incubation with a selection agent): 12 days
SELECTION AGENT (mutation assays): trifluorothymidine (TFT)
NUMBER OF REPLICATIONS: only negative and solvent controls were plated in duplicate; mutant frequency was counted in 4 plates for all treatment groups.
NUMBER OF CELLS EVALUATED: four 96-well plates at a density of approximately 2000 cells/well
DETERMINATION OF CYTOTOXICITY
- Method: suspension growth (SG; the number of times the cell number increased from the starting
cell density); relative total growth (RTG; the product of the relative suspension growth [RTG] and the
relative cloning efficiency [RCE]) - Rationale for test conditions:
- The assay was considered acceptable if the following criteria were met:
1. At least 3 out of 4 of the 96-well plates were scorable;
2. The cloning efficiency of the negative and/or solvent controls was between 65-120%;
3. The spontaneous mutant frequency in the negative and/or solvent controls was between 50 to 170 mutant per 10E6 cells;
4. The cell number of negative and/or solvent controls increased between 8 to 32 fold during the 2-day growth period; and
5. Positive controls responded appropriately and produced either at least 300 mutants per 10E6 cells with at least 40% of the colonies being small OR indcued a small colony mutant frequency of at least 150 mutants per 10E6 cells. The RTG for positive controls also must be greater than 10%. - Evaluation criteria:
- The test item is considered mutagenic if the following criteria are met:
- The induced mutant frequency meets or exceeds the Global Evaluation factor (GEF) of 126 mutants per 10E6 cells
- A dose-dependent increase in mutant frequency is detected.
Besides, combined with a positive effect in the mutant frequency, an increased occurrence of small colonies (≥ 40% of total colonies) is an indication for potential clastogenic effects and/or chromosomal aberrations.
According to the OECD guideline, the biological relevance is considered first for the interpretation of results. Statistical methods might be used as an aid in evaluation of the test result.
A test item is considered to be negative if the induced mutant frequency is below the GEF and the trend of the test is negative. - Statistics:
- Statistical significance at the 5% level (p < 0.05) was evaluated for mutant frequency by means of the non-parametric Mann-Whitney test.
- Key result
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Results showed that there was a statistically significant increase in mutant frequency in mouse lymphoma cells at 7.5 and 10 mM with metabolic activation when compared to solvent controls; however, these increases did not exceed 126 mutants per 10E6 cells. Therefore, these increases were not considered to be a positive response.
- Conclusions:
- In an OECD 490 study, the test material is not considered to be mutagenic in an in vitro mammalian cell gene mutation assay (thymidine kinase locus) in mouse lymphoma L5178Y cells both with and without metabolic activation.
- Endpoint:
- in vitro cytogenicity / micronucleus study
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 08 Mar - 27 Jun 2006
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- other: OECD guideline 487: In vitro mammalian cell micronucleus test (2004)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Bayerisches Landesamt für Arbeitsschutz, Arbeitsmedizin und Sicherheitstechnik, München, Germany
- Type of assay:
- in vitro mammalian cell micronucleus test
- Target gene:
- Not applicable
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- Type and identity of media:
Complete culture medium: MEM medium supplemented with
- 10%(v/v) fetal calf serum (FCS)
- 220 µg/ml penicillin/streptomycin
Treatment medium: MEM medium supplemented with
- 220 µg/ml penicillin/streptomycin
- 1.5 µg/ml cytochalasine B
- 220 µg/ml sodium pyruvate - Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 liver microsomal fraction of phenobarbital and β-naphtoflavone induced rats
- Test concentrations with justification for top dose:
- Pre-experiment:
- 7.8, 15.6, 31.3, 62.5, 125, 250, 500, 1000, 2500, 5000 µg/mL
Main experiment I:
- 125, 250, 500, 1000, 2500, 5000 µg/mL (with and without metabolic activation)
Main experiment II:
- 31.3, 62.5, 125, 250, 500, 1000, 2500, 5000 µg/mL (without metabolic activation)
- 500, 1000, 2000, 3000, 4000, 5000 µg/mL (with metabolic activation) - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: The solvent was compatible with the survival of the cells and the S9 activity. - Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: Ethylmethanesulfonate, 600 and 900 µg/mL in MEM, -S9; Cyclophosphamide, 2.5 µg/mL in MEM, +S9 (clastogenic control substance); Colcemide 0.08 and 0.8 µg/mL (aneugenic control substance)
- Details on test system and experimental conditions:
- Example:
METHOD OF APPLICATION: in medium
DURATION
- Exposure duration: 4, and 24 h
- Fixation time (start of exposure up to fixation or harvest of cells): 4 h treatment: 24 h; 24 h treatment: 24 h;
STAIN (for cytogenetic assays): Acridine Orange solution
NUMBER OF REPLICATIONS: 2
NUMBER OF CELLS EVALUATED: 2000 binucleated cells per concentration
DETERMINATION OF CYTOTOXICITY
- Method: Cytokinesis-Block Proliferation index (CBPI) - Evaluation criteria:
- There are several criteria for determining a positive result:
- a concentration-related increase or reproducible increase in the number of cells containing micronuclei
- a biologically relevant increase in the number of cells containing micronuclei for at least one of the dose groups, which is higher than the laboratory negative control range.
Statistical methods may be used as an aid in evaluating the test results. Statistical significance should not be the only determination of a positive response. A test item is considered to be negative if there is no biologically relevant increase in the percentages of cells with micronuclei above concurrent control levels, at any dose group. - Statistics:
- χ² test, one-sided, p < 0.05
- Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- 1000 µg/mL (main experiment I), ≥ 1000 µg/mL (main experiment II)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- ≥ 2500 µg/mL (main experiment II)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: No precipitation of the test item was noted in all dose groups evaluated.
COMPARISON WITH HISTORICAL CONTROL DATA:
In experiment I and II (with and without metabolic activation) the micronucleated cells frequencies of the negative control and the solvent control were within the historical control data of the negative control. The number of micronucleated cells found after treatment with the test item was within the historical control data range of the negative control.
RANGE-FINDING/SCREENING STUDIES:
According to the used draft guideline the highest recommended concentration tested was 5000 µg/mL. - Conclusions:
- Interpretation of results: negative
Based on the results of the study the test material is considered not to be clastogenic in this mammalian micronucleus test in vitro.
Referenceopen allclose all
Table 1: Test results of main test 1 (Plate incorporation test).
With or without S9-Mix |
Test substance concentration |
Mean number of revertant colonies per plate in the plate incorporation test |
|||||
(μg/plate) |
(average of 3 plates±standard deviation) |
||||||
|
Base-pair substitution type |
Frameshift type |
|||||
|
TA 100 |
TA 102 |
TA 1535 |
TA1537 |
TA98 |
||
– |
A. dest. |
124±8 |
327±6 |
27±4 |
12±7 |
31±3 |
|
– |
Solvent control |
99±11 |
273±16 |
28±7 |
11±6 |
33±2 |
|
– |
31.6 |
106±19 |
286±16 |
24±5 |
14±6 |
36±2 |
|
– |
100 |
109±4 |
279±11 |
22±6 |
15±5 |
27±8 |
|
– |
316 |
104±9 |
301±7 |
23±5 |
15±2 |
33±6 |
|
– |
1000 |
115±4 |
294±8 |
21±4 |
17±3 |
27±2 |
|
– |
2500 |
103±14 |
319±26 |
19±4 |
12±3 |
28±8 |
|
– |
5000 |
116±5 |
308±19 |
24±9 |
12±6 |
30±8 |
|
Positive controls, –S9 |
Name |
sodium azide |
MMS |
sodium azide |
4-NOPD |
4-NOPD |
|
Concentrations (μg/plate) |
10 |
1 µL/plate |
10 |
40 |
10 |
||
Average of 3 plates±sd |
402±28 |
1724±129 |
1032±46 |
179±11 |
774±59 |
||
+ |
A. dest. |
124±22 |
355±56 |
12±2 |
15±4 |
46±9 |
|
+ |
Solvent control |
116±13 |
289±31 |
11±3 |
13±1 |
36±7 |
|
+ |
31.6 |
116±7 |
330±28 |
15±7 |
17±2 |
38±2 |
|
+ |
100 |
108±16 |
369±40 |
21±1 |
14±1 |
41±4 |
|
+ |
316 |
116±14 |
330±23 |
16±7 |
13±9 |
38±12 |
|
+ |
1000 |
113±17 |
360±19 |
16±4 |
19±3 |
35±1 |
|
+ |
2500 |
128±4 |
352±5 |
11±3 |
13±4 |
34±4 |
|
+ |
5000 |
130±9 |
375±23 |
15±6 |
13±3 |
38±6 |
|
Positive controls,+S9 |
Name |
2-aminoanthracene |
2-aminoanthracene |
2-aminoanthracene |
2-aminoanthracene |
2-aminoanthracene |
|
Concentrations (μg/plate) |
2.5 |
10 |
2.5 |
2.5 |
2.5 |
||
Average of 3 plates±sd |
1991±36 |
804±20 |
226±29 |
282±9 |
1207±142 |
Table 2: Test results of main test 2 (Pre-incubation test).
With or without S9-Mix |
Test substance concentration |
Mean number of revertant colonies per plate in the pre-incubation test |
|||||
(μg/plate) |
(average of 3 plates±standard deviation) |
||||||
|
Base-pair substitution type |
Frameshift type |
|||||
|
TA 100 |
TA 102 |
TA 1535 |
TA1537 |
TA98 |
||
– |
A. dest. |
113±11 |
192±19 |
21±4 |
17±6 |
35±5 |
|
– |
Solvent control |
99±5 |
141±8 |
17±4 |
11± |
27±4 |
|
– |
31.6 |
128±3 |
166±12 |
16±4 |
17±7 |
25±4 |
|
– |
100 |
115±18 |
159±11 |
20±1 |
17±4 |
26±3 |
|
– |
316 |
117±21 |
151±1 |
24±2 |
15±4 |
25±3 |
|
– |
1000 |
114±1 |
154±20 |
17±4 |
17±1 |
25±3 |
|
– |
2500 |
123±5 |
131±9 |
24±1 |
17±2 |
24±5 |
|
– |
5000 |
123±10 |
166±6 |
23±3 |
17±1 |
31±4 |
|
Positive controls, –S9 |
Name |
sodium azide |
MMS |
sodium azide |
4-NOPD |
4-NOPD |
|
Concentrations (μg/plate) |
10 |
1 µL/plate |
10 |
40 |
10 |
||
Average of 3 plates±sd |
540±49 |
2246±80 |
1168±84 |
152±15 |
848±29 |
||
+ |
A. dest. |
143±12 |
304±32 |
16±6 |
24±8 |
45±5 |
|
+ |
Solvent control |
128±9 |
211±39 |
11±2 |
11±0 |
39±11 |
|
+ |
31.6 |
132±10 |
258±15 |
18±2 |
13±3 |
38±10 |
|
+ |
100 |
127±12 |
246±1 |
13±6 |
18±8 |
43±12 |
|
+ |
316 |
120±8 |
223±17 |
15±3 |
14±2 |
33±4 |
|
+ |
1000 |
128±3 |
221±25 |
19±4 |
11±4 |
42±2 |
|
+ |
2500 |
122±25 |
209±12 |
12±6 |
15±4 |
38±8 |
|
+ |
5000 |
122±22 |
233±31 |
21±3 |
16±2 |
35±9 |
|
Positive controls,+S9 |
Name |
2-aminoanthracene |
2-aminoanthracene |
2-aminoanthracene |
2-aminoanthracene |
2-aminoanthracene |
|
Concentrations (μg/plate) |
2.5 |
10 |
2.5 |
2.5 |
2.5 |
||
Average of 3 plates±sd |
2373±144 |
839±197 |
178±31 |
204±44 |
2033±238 |
MMS - Methylmethanesulfonate
4 -NOPD - 4 -nitro-o-phenylene-diamine
Table 1: Chromosome aberrations in Chinese hamster V79 cells in the absence/presence of metabolic activation
Test item |
Concentration |
Mitotic Index |
Aberrant cells in % |
|
|
in µg/mL |
in % |
with gaps |
without gaps |
Exposure period 4 h, fixation time 20 h, without S9-mix |
||||
Control |
0 |
112 |
3.5 |
1.0 |
DMSO |
0 |
100 |
3.0 |
2.0 |
EMS |
600 |
138 |
12.0 |
9.5 |
Test substance |
125 |
91 |
8.0 |
5.0 |
250 |
65 |
6.0 |
4.0 |
|
1000 |
63 |
2.0 |
2.0 |
|
5000 |
48 |
3.0 |
1.5 |
|
Exposure period 4 h, fixation time 20 h, with S9-mix |
||||
Control |
0 |
119 |
5.0 |
3.0 |
DMSO |
0 |
100 |
6.0 |
3.0 |
CPA |
0.83 |
69 |
17.5 |
13.0 |
Test substance |
1000 |
120 |
8.0 |
5.0 |
2500 |
98 |
10.0 |
8.5 |
|
5000 |
104 |
8.0 |
7.5 |
|
Exposure period 20 h, fixation time 20 h, without S9-mix |
||||
Control |
0 |
72 |
4.0 |
2.0 |
DMSO |
0 |
100 |
5.0 |
4.0 |
EMS |
600 |
51 |
28.5 |
24.5 |
Test substance |
500 |
42 |
8.5 |
3.0 |
1000 |
36 |
7.0 |
4.0 |
|
2500 |
47 |
7.5 |
7.0 |
|
Exposure period 4 h, fixation time 20 h, with S9-mix |
||||
Control |
0 |
69 |
2.5 |
1.8 |
DMSO |
0 |
100 |
6.0 |
4.0 |
CPA |
0.83 |
54 |
16.4 |
12.7 |
Test substance |
3000 |
78 |
7.0 |
5.5 |
4000 |
66 |
8.3 |
4.5 |
|
5000 |
66 |
7.3 |
5.3 |
EMS: Ethylmethanesulfonate
CPA: Cyclophosphamide
Table 2: Test for cytotoxicity
Concentration [µg/ml] |
Mitotic index metabolic activation
|
|||
without S9-mix relative [%] |
with S9-mix relative [%] |
|||
Control |
122 |
144 |
70 |
90 |
DMSO |
85 |
100 |
78 |
100 |
15.6 |
75 |
88 |
79 |
101 |
31.3 |
80 |
94 |
81 |
104 |
62.5 |
74 |
87 |
55 |
71 |
125 |
65 |
76 |
81 |
104 |
250 |
79 |
93 |
69 |
88 |
500 |
52 |
61 |
63 |
81 |
1000 |
45 |
53 |
56 |
72 |
2500 |
49 |
58 |
71 |
91 |
5000 |
63 |
74 |
53 |
68 |
Table 1: Experiment I - 4 h exposure - With Metabolic Activation
Concentration |
Relative cloning efficiency [%] |
Relative Total Growth [%] |
Mutants per 10E+06 surviving cells |
Mutation frequency |
Negative 1 |
105.0 |
109.2 |
115.2 |
--- |
Negative 2 |
78.9 |
78.9 |
119.8 |
--- |
Solvent (THF) 1 |
100.0 |
100.0 |
122.4 |
--- |
Solvent (THF) 2 |
100.0 |
100.0 |
95.1 |
--- |
0.10 |
106.9 |
99.6 |
112.4 |
3.7 |
0.25 |
90.5 |
97.4 |
124.8 |
16.1 |
0.5 |
86.4 |
87.1 |
111.2 |
2.4 |
1.0 |
96.5 |
97.1 |
93.3 |
-15.4 |
2.5 |
96.5 |
87.2 |
126.9 |
18.2 |
5.0 |
103.2 |
98.9 |
135.0 |
26.2 |
7.5 |
80.1 |
72.7 |
221.1 |
112.3 * |
10 |
96.5 |
92.5 |
203.4 |
94.6 * |
B[a]P, 3.5 µg/mL |
66.4 |
48.7 |
750.5 |
641.7 |
B[a]P Benzo[a]pyrene
* p < 0.05
Table 2: Experiment I - 4 h exposure - Without Metabolic Activation
Concentration |
Relative cloning efficiency [%] |
Relative Total Growth [%] |
Mutants per 10E+06 surviving cells |
Mutation frequency |
Negative 1 |
103.4 |
105.4 |
103.5 |
--- |
Negative 2 |
107.0 |
114.2 |
95.7 |
--- |
Solvent (THF) 1 |
100.0 |
100.0 |
109.7 |
--- |
Solvent (THF) 2 |
100.0 |
100.0 |
84.2 |
--- |
0.10 |
100.0 |
96.2 |
121.7 |
24.8 |
0.25 |
95.2 |
96.2 |
137.2 |
40.2 |
0.5 |
108.9 |
102.1 |
108.8 |
11.8 |
1.0 |
86.6 |
75.3 |
116.3 |
19.3 |
2.5 |
98.3 |
91.8 |
120.0 |
23.0 |
5.0 |
112.9 |
97.8 |
88.9 |
-8.1 |
7.5 |
100.0 |
87.2 |
93.4 |
-3.6 |
10 |
96.7 |
86.2 |
112.3 |
15.3 |
EMS, 300 µg/mL |
85.3 |
76.5 |
910.9 |
813.9 |
MMS, 10 µg/mL |
69.5 |
57.1 |
615.9 |
518.9 |
EMS Ethylmethanesulfonate
MMS Methylmethanesulfonate
Table 1: CBPI and micronucleus induction in V79 cells
Test item |
Concentration |
CBPI |
Number of cells with MN [%] |
|
in µg/mL |
in % |
|
Exposure period 4 h, fixation time 24 h, without S9-mix |
|||
Negative control |
0 |
95 |
0.95 |
DMSO |
0 |
100 |
0.75 |
EMS |
900 |
74 |
7.15 |
Colcemid |
0.8 |
81 |
3.05 |
Test substance |
1000 |
120 |
1.05 |
2500 |
110 |
1.05 |
|
5000 |
103 |
1.05 |
|
Exposure period 4 h, fixation time 24 h, with S9-mix |
|||
Negative control |
0 |
92 |
1.0 |
DMSO |
0 |
100 |
0.9 |
CPA |
2.5 |
55 |
10.7 |
Test substance |
1000 |
64 |
1.9 |
2500 |
70 |
1.8 |
|
5000 |
78 |
1.65 |
|
Exposure period 4 h, fixation time 24 h, with S9-mix |
|||
Negative control |
0 |
111 |
1.9 |
DMSO |
0 |
100 |
1.2 |
CPA |
2.5 |
68 |
8.6 |
Test substance |
500 |
95 |
1.55 |
1000 |
67 |
1.6 |
|
2000 |
50 |
2.2 |
|
4000 |
59 |
2.1 |
|
Exposure period 24 h, fixation time 24 h, without S9-mix |
|||
Negative control |
0 |
101 |
1.75 |
DMSO |
0 |
100 |
2.1 |
EMS |
600 |
41 |
7.45 |
Colcemid |
0.08 |
72 |
15.7 |
Test substance |
1000 |
93 |
1.6 |
2500 |
57 |
1.35 |
|
5000 |
54 |
1.75 |
EMS: Ethylmethanesulfonate (positive control)
CPA: Cyclophosphamide (positive control)
CBPI: Cytokinesis-Block Proliferation Index
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Genetic toxicity (mutagenicity) in bacteria in vitro
A key genetic toxicity study addressing mutagenicity in bacteria in vitro with methyl-N-{[dimethoxy(methyl)silyl]methyl}carbamate (CAS 23432-65-7) is available and was performed according to OECD TG 471 (Ames test) and in compliance with GLP (BSL, 2004).
The strains Salmonella typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102 were tested according to the plate incorporation (experiment I) and pre-incubation (experiment II) procedure in the absence and presence of a metabolic activation system (Aroclor 1254-induced rat liver S9-mix). Two independent experiments were conducted in three repetitions at each concentration from 31.6 to 5000 µg/plate. No significant increase in the number of revertants was observed in any of the tester strains with and without metabolic activation. No cytotoxicity and no precipitation of the test material were observed at any tested concentration. Appropriate negative, solvent (DMSO) and positive controls were included into the test and gave the expected results. Based on the results of the study the test material was considered to be not mutagenic in bacteria under the conditions of the test.
Genetic toxicity (clastogenicity) in mammalian cells in vitro
Two studies assessing clastogenicity in mammalian cells in vitro with methyl-N-{[dimethoxy(methyl)silyl]methyl}carbamate (CAS 23432-65-7) are available.
In a chromosome aberration study performed according to OECD TG 473 and in compliance with GLP Chinese hamster lung fibroblasts (V79) were treated with methyl-N-{[dimethoxy(methyl)silyl]methyl}carbamate or vehicle (DMSO) in two independent experiments in the absence or presence of a metabolic activation system (Aroclor-induced rat liver S9-mix) at concentrations of 125, 250, 500, 1000, 2500, 5000 μg/mL (experiment I with and without S9 -mix, experiment II without S9-mix) and 500, 1000, 2000, 3000, 4000, 5000 μg/mL (experiment II with S9-mix) for 4 or 20 hours (without S9-mix) and 4 hours (with S9-mix) (BSL, 2004). Fixation of the cells was performed 20 hours after start of exposure with the test material. Appropriate solvent, negative and positive controls were included in the test and gave the expected results. Clastogenicity was recorded at concentrations of 2500 and 5000 µg/mL (experiment I with S9-mix) and 2500 µg/mL (experiment II without S9-mix). Cytotoxicity was observed at concentrations greater than 4000 µg/mL (experiment II with S9-mix) and ≥250 µg/mL (experiment I) and ≥500 µg/ml (experiment II) without S9-mix. No precipitation of the test material was noted at any tested concentration. The results of the study are inconclusive as no clear dose response relation could be observed and clastogenicity mainly occurred at cytotoxic concentration. Therefore, an additional in vitro micronucleus test was performed.
In this in vitro micronucleus test performed according to OECD TG 487 and in compliance with GLP Chinese hamster lung fibroblasts (V79) were treated with methyl-N-{[dimethoxy(methyl)silyl]methyl}carbamate or vehicle (DMSO) in two independent experiments in the absence or presence of a metabolic activation system (Aroclor-induced rat liver S9-mix) at concentrations of 125, 250, 500, 1000, 2500, 5000 μg/mL (experiment I with and without S9-mix), 31.3, 62.5, 125, 250, 500, 1000, 2500, and 5000 μg/mL (experiment II without S9-mix) and 500, 1000, 2000, 3000, 4000 and 5000 µg/mL (experiment II with S9-mix) for 4 or 24 hours (without S9-mix) and 4 hours (with S9-mix) (BSL, 2006). Fixation of the cells was performed 24 hours after start of exposure with the test material. Appropriate solvent, negative and positive controls were included in the test and gave the expected results. The number of micronucleated cells found after treatment with the test item was within the historical control data range of the negative control. Cytotoxicity was observed at concentrations of 1000 µg/mL (experiment I) and ≥1000 µg/mL (experiment II) with metabolic activation and ≥2500 µg/mL (experiment II) without metabolic activation. No precipitation of the test material was noted at any tested concentration. Based on the results of the study the test material is considered not to be clastogenic in this mammalian micronucleus test in vitro.
Based on the results of these two studies taken together, it is assumed that the substance has no clastogenic potential.
Genetic toxicity (mutagenicity) in mammalian cells in vitro
An in vitro mammalian cell gene mutation assay (thymidine kinase locus) in mouse lymphoma L5178Y cells both with and without metabolic activation was performed using methyl-N-{[dimethoxy(methyl)silyl]methyl}carbamate (Eurofins, 2016). The study was conducted in accordance with OECD 490. For the study, mouse lymphoma L5178Y cells were treated with the test material or vehicle (tetrahydrofuran) at concentrations of 0.10, 0.25, 0.5, 1.0, 2.5, 5.0, 7.5, or 10 mM for 4 hours when in the presence of a metabolic activation system (phenobarbital/β-naphtholflavone induced rat liver S9-mix). The test material was also evaluated without a metabolic activation system at concentrations of 0.10, 0.25, 0.5, 1.0, 2.5, 5.0, 7.5, or 10 mM for 4 hours. Appropriate solvent and positive controls were included in the test and gave the expected result. No cytotoxicity was observed either with or without metabolic activation. Mutant frequency was comparable to negative controls in the assay conducted without metabolic activation. Results showed that there was a statistically significant increase in mutant frequency in mouse lymphoma cells at 7.5 and 10 mM with metabolic activation when compared to solvent controls; however, these increases did not meet the criteria of a positive response (i.e., exceeding 126 mutants per 10E6 cells). Therefore, these increases were not considered to be a positive response. Based on these results, the test material is not considered to be mutagenic in an in vitro mammalian cell gene mutation assay (thymidine kinase locus) in mouse lymphoma L5178Y cells both with and without metabolic activation.
Justification for classification or non-classification
The available data on genetic toxicity of the test substance methyl-N-{[dimethoxy(methyl)silyl]methyl}carbamate (CAS 23432-65-7) do not meet the criteria for classification according to Regulation (EC) No 1272/2008, and are therefore conclusive but not sufficient for classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.